Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 19
255
Views
5
CrossRef citations to date
0
Altmetric
Short Communications

UHPLC-HRMS based flavonoid profiling of the aerial parts of Chenopodium foliosum Asch. (Amaranthaceae)

ORCID Icon & ORCID Icon
Pages 3336-3340 | Received 22 Sep 2019, Accepted 31 Oct 2019, Published online: 12 Nov 2019
 

Abstract

Chenopodium foliosum Asch. has been recognised by Bulgarian legislation as a medicinal plant. The decoction of its aerial parts has been used for treatment of cancer, as an immunostimulant and antioxidant drug. An UHPLC-HRMS profiling method was used for a comprehensive study of flavonoid composition of C. foliosum. Fourty flavonoid glycosides with nine aglycones (patuletin, gomphrenol, spinacetin, 6-methoxykaempferol, kaempferol, quercetin, isorhamnetin, 3,5,3',4'-tetrahydroxy-6,7-methylenedioxyflavone and 3,5,4'-trihydroxy-3'-methoxy-6,7-methylenedioxyflavone) were detected. Kaempferol, quercetin and isorhamnetin glycosides were identified as minor components. A pseudo MS3 experiment aided at discriminating 6-methoxykaempferol and isorhamnetin glycosides. Flavonoid composition dominated by di-, triglycosides and acylated flavonoids. Acid hydrolysis and GS-MS analysis confirmed the presence of D-glucose, D-apiose and L-rhamnose. Ten flavonoids were reported here for the first time.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.